within Pharmacolibrary.Drugs.ATC.N;

model N05BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.45,
    Cl             = 0.6,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Medazepam is a long-acting benzodiazepine that is used primarily as an anxiolytic for the treatment of anxiety and related disorders. It acts as a prodrug, being metabolized to active benzodiazepines such as diazepam, nordazepam, and oxazepam. While previously used in Europe and other regions, its approval and clinical use is now limited in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult population based on available class data for oral medazepam. There are no comprehensive, peer-reviewed, primary publications specifically reporting detailed pharmacokinetic compartmental modeling parameters for medazepam in healthy subjects.</p><h4>References</h4><ol><li><p>Hailey, DM, &amp; Baird, ES (1979). Plasma concentrations of medazepam and its metabolites after oral administration. <i>British journal of anaesthesia</i> 51(6) 493–496. DOI:<a href=&quot;https://doi.org/10.1093/bja/51.6.493&quot;>10.1093/bja/51.6.493</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37864/&quot;>https://pubmed.ncbi.nlm.nih.gov/37864</a></p></li><li><p>Lucek, RW, et al., &amp; Schwartz, MA (1975). Further studies on medazepam metabolism in the rat. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 3(4) 297–302. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/240660/&quot;>https://pubmed.ncbi.nlm.nih.gov/240660</a></p></li><li><p>Shader, RI, &amp; Greenblatt, DJ (1977). Clinical implications of benzodiazepine pharmacokinetics. <i>The American journal of psychiatry</i> 134(6) 652–656. DOI:<a href=&quot;https://doi.org/10.1176/ajp.134.6.652&quot;>10.1176/ajp.134.6.652</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17302/&quot;>https://pubmed.ncbi.nlm.nih.gov/17302</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05BA03;
